Weihe Zhang - Concepedia

Concepedia

Author

Weihe Zhang

University of North Carolina at Chapel Hill ORCID

Also Known As

Bigi, Rachele, Earp, H. Shelton, Frye, Stephen V., Hill, Amanda A., Lee, Minjung, Liu, Jing, Liu, Qingyang, Nichols, James, Pahwa, S., Shah, Neil P.

109

Publications

1.9K

Citations

21

H-Index

52

Concepts

All Affiliations

University of North Carolina at Chapel Hill University of Colorado Denver Emory University Children's Healthcare of Atlanta University of Colorado Anschutz Medical Campus

WZ

About

Weihe Zhang is an author at University of North Carolina at Chapel Hill specializing in medicine, pharmacology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	16	1.5K
2	Cell Biology	10	10	1.2K
3	Natural Sciences	7	7	933
4	Biochemistry	7	7	969
5	Engineering	2	2	27

Weihe Zhang

×

26

Publications

1.9K

Citations

21

H-Index

	Year	Citations
A Small-Molecule Inhibitor of Glucose Transporter 1 Downregulates Glycolysis, Induces Cell-Cycle Arrest, and Inhibits Cancer Cell Growth <i>In Vitro</i> and <i>In Vivo</i> Yi Liu, Yanyan Cao, Weihe Zhang, Molecular Cancer Therapeutics Chemoprevention StrategyCellular PharmacologyMetabolic RemodelingWarburg EffectInsulin Signaling	2012	544
<b>UNC2025</b>, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor Weihe Zhang, Deborah DeRyckere, Debra M. Hunter, Journal of Medicinal Chemistry Useful SelectivityPharmacotherapyPharmaceutical ChemistryMouse Bone MarrowMyeloid Neoplasia	2014	157
MERTK receptor tyrosine kinase is a therapeutic target in melanoma Jennifer Schlegel, Maria J. Sambade, Susan Sather, Journal of Clinical Investigation Mertk ExpressionSkin CancerMedicineReceptor Tyrosine KinaseMelanoma	2013	142
Total Synthesis of Absinthin Weihe Zhang, Shengjun Luo, Fang, Journal of the American Chemical Society	2004	104
Small compound inhibitors of basal glucose transport inhibit cell proliferation and induce apoptosis in cancer cells via glucose-deprivation-like mechanisms Yi Liu, Weihe Zhang, Yanyan Cao, Cancer Letters Glucose-deprivation-like MechanismsGliomaMedicineDiabetesApoptosis	2010	86
The MERTK/FLT3 inhibitor MRX-2843 overcomes resistance-conferring FLT3 mutations in acute myeloid leukemia Katherine A. Minson, Catherine C. Smith, Deborah DeRyckere, JCI Insight Fms-like Tyrosine KinaseMixed-phenotype Acute LeukemiaResistance-conferring Flt3 MutationsImmunologyTumor Biology	2016	75
UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia Models Deborah DeRyckere, Alisa B. Lee‐Sherick, Madeline G. Huey, Clinical Cancer Research	2016	71
Novel inhibitors of basal glucose transport as potential anticancer agents Weihe Zhang, Yi Liu, Xiaozhuo Chen, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryMedicineNatural SciencesDiabetes	2010	70
Pseudo-Cyclization through Intramolecular Hydrogen Bond Enables Discovery of Pyridine Substituted Pyrimidines as New Mer Kinase Inhibitors Weihe Zhang, Dehui� Zhang, Michael A. Stashko, Journal of Medicinal Chemistry Combinatorial ChemistryPyridinepyrimidine AnaloguesHeterocycle ChemistryTumor BiologyMedicinal Chemistry	2013	68
UNC1062, a new and potent Mer inhibitor Jing Liu, Weihe Zhang, Michael A. Stashko, European Journal of Medicinal Chemistry BiochemistryPotent Mer InhibitorMedicinePharmacotherapyDrug Development	2013	64

Page 1